More precisely, a high DEPCyMCase activity (i.e., a high PON1 concentration) seems protective for CAD risk in subjects with MS, while the highest risk for CAD was observed among subjects with MS and concomitant low levels of DEPCyMCase activity (i.e., a low PON1 concentration). Here, PON1 is linked to coronary artery disorder.